CNBX Pharmaceuticals Inc. (CNBX)
USD 0.01
(5.93%)
USD 0.01
(5.93%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.42 USD | 86.36% |
| 2022 | -3.08 USD | -42.59% |
| 2021 | -2.16 USD | 22.3% |
| 2020 | -2.78 USD | -369.9% |
| 2019 | 1.03 USD | 127.39% |
| 2018 | -3.76 USD | -79.05% |
| 2017 | -2.10 USD | -483.33% |
| 2016 | -0.36 USD | 44.62% |
| 2015 | -0.65 USD | -103.13% |
| 2014 | -0.32 USD | 93.57% |
| 2013 | -4.98 USD | -3220.0% |
| 2012 | -0.15 USD | 98.42% |
| 2011 | -9.47 USD | 6.61% |
| 2010 | -10.14 USD | 0.0% |
| 2009 | -10.14 USD | -319.01% |
| 2008 | -2.42 USD | -18.05% |
| 2007 | -2.05 USD | 14.58% |
| 2006 | -2.40 USD | -179.07% |
| 2005 | -0.86 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.01 USD | -64.06% |
| 2024 Q1 | -0.01 USD | 74.8% |
| 2024 Q3 | -0.00 USD | 60.0% |
| 2023 Q1 | -0.29 USD | 27.5% |
| 2023 Q4 | -0.03 USD | -35.83% |
| 2023 FY | - USD | 86.36% |
| 2023 Q2 | -1.34 USD | -362.07% |
| 2023 Q3 | -0.02 USD | 98.6% |
| 2022 Q3 | -0.59 USD | 58.74% |
| 2022 FY | - USD | -42.59% |
| 2022 Q1 | -1.21 USD | -116.07% |
| 2022 Q2 | -1.43 USD | -18.18% |
| 2022 Q4 | -0.40 USD | 32.2% |
| 2021 Q4 | -0.56 USD | 52.14% |
| 2021 FY | - USD | 22.3% |
| 2021 Q1 | -0.60 USD | 7.69% |
| 2021 Q2 | -0.47 USD | 21.67% |
| 2021 Q3 | -1.17 USD | -148.94% |
| 2020 FY | - USD | -369.9% |
| 2020 Q3 | -0.64 USD | 16.88% |
| 2020 Q2 | -0.77 USD | 83.33% |
| 2020 Q1 | -4.62 USD | -269.6% |
| 2020 Q4 | -0.65 USD | -1.56% |
| 2019 FY | - USD | 127.39% |
| 2019 Q3 | -0.49 USD | -106.28% |
| 2019 Q1 | -0.64 USD | 12.33% |
| 2019 Q2 | 7.80 USD | 1318.75% |
| 2019 Q4 | -1.25 USD | -155.1% |
| 2018 Q1 | -0.54 USD | 58.14% |
| 2018 Q4 | -0.73 USD | 16.09% |
| 2018 FY | - USD | -79.05% |
| 2018 Q3 | -0.87 USD | 46.63% |
| 2018 Q2 | -1.63 USD | -201.85% |
| 2017 Q1 | -0.16 USD | -102.53% |
| 2017 Q4 | -1.29 USD | -416.0% |
| 2017 Q3 | -0.25 USD | 45.65% |
| 2017 FY | - USD | -483.33% |
| 2017 Q2 | -0.46 USD | -187.5% |
| 2016 FY | - USD | 44.62% |
| 2016 Q3 | -0.03 USD | 82.18% |
| 2016 Q1 | 0.53 USD | 320.83% |
| 2016 Q2 | -0.17 USD | -132.08% |
| 2016 Q4 | -0.08 USD | -160.73% |
| 2015 Q2 | -0.07 USD | 54.8% |
| 2015 FY | - USD | -103.13% |
| 2015 Q4 | -0.24 USD | -33.33% |
| 2015 Q3 | -0.18 USD | -165.49% |
| 2015 Q1 | -0.15 USD | 25.0% |
| 2014 Q4 | -0.20 USD | -105.13% |
| 2014 Q3 | -0.10 USD | -4.39% |
| 2014 Q2 | -0.09 USD | 64.08% |
| 2014 Q1 | -0.26 USD | -1006.38% |
| 2014 FY | - USD | 93.57% |
| 2013 Q2 | -0.41 USD | 69.4% |
| 2013 Q1 | -1.34 USD | -205.51% |
| 2013 Q3 | -0.42 USD | -2.44% |
| 2013 FY | - USD | -3220.0% |
| 2013 Q4 | -0.02 USD | 94.4% |
| 2012 Q2 | -0.16 USD | 82.22% |
| 2012 Q1 | -0.90 USD | -1611.03% |
| 2012 Q3 | -0.35 USD | -118.75% |
| 2012 Q4 | 1.27 USD | 462.86% |
| 2012 FY | - USD | 98.42% |
| 2011 Q1 | -0.78 USD | -4162.3% |
| 2011 FY | - USD | 6.61% |
| 2011 Q4 | -0.05 USD | 98.33% |
| 2011 Q3 | -3.15 USD | -1311.54% |
| 2011 Q2 | 0.26 USD | 133.33% |
| 2010 Q4 | -0.02 USD | 99.69% |
| 2010 Q3 | -5.95 USD | -3618.75% |
| 2010 Q2 | -0.16 USD | 91.3% |
| 2010 Q1 | -1.84 USD | -2235.03% |
| 2010 FY | - USD | 0.0% |
| 2009 FY | - USD | -319.01% |
| 2009 Q4 | -0.08 USD | -2.47% |
| 2009 Q3 | -0.08 USD | 35.92% |
| 2009 Q2 | -0.12 USD | 75.51% |
| 2009 Q1 | -0.49 USD | -4017.65% |
| 2008 FY | - USD | -18.05% |
| 2008 Q2 | -0.16 USD | 75.0% |
| 2008 Q1 | -0.64 USD | -21968.97% |
| 2008 Q3 | -0.20 USD | -25.0% |
| 2008 Q4 | -0.01 USD | 94.05% |
| 2007 Q2 | -1.10 USD | -25.0% |
| 2007 Q3 | -0.19 USD | 82.73% |
| 2007 Q4 | -0.00 USD | 98.47% |
| 2007 FY | - USD | 14.58% |
| 2007 Q1 | -0.88 USD | -14326.23% |
| 2006 Q2 | -0.66 USD | 8.33% |
| 2006 FY | - USD | -179.07% |
| 2006 Q1 | -0.72 USD | 0.0% |
| 2006 Q3 | -0.29 USD | 56.06% |
| 2006 Q4 | -0.01 USD | 97.9% |
| 2005 FY | - USD | 0.0% |